3_edited.png

Longevity
Investors
Conference

Next online event
27th September, 2021
03:00 PM - 07:00 PM CET

What is Longevity?

 

Longevity is defined as "long life" or "a great duration of life."

 

The term comes from the Latin word longaevitās. In this word, you can see how the words longus (long) and aevum (age) combine into a concept that means an individual who lives a long time.

About Longevity Investors Conference

 

Longevity will be one of the largest, if not the largest, investment opportunity in the decades to come.

The Longevity Investors Conference provides relevant insights into the subject, expert education, investment opportunities, excellent networking opportunities and a great setting in an exclusive location.

The conference is targeting investors from (U)HNWIs, Family Offices, VCs, Private Equity Funds, Private Banks and Asset Managers.

Sub-topics are (radical) life-extension, rejuvenation and biostasis.

 

Sneak Preview Speakers 2021

The full Speaker List will be announced soon

GREG%20HUNG_edited.png
Bildschirmfoto 2021-05-05 um 18.02.35.pn
Bildschirmfoto 2021-05-05 um 18.02.16.pn

Dr. Aubrey de Grey

Chief Science Officer, SENS Research Foundation

Dr. Aubrey de Grey is a biomedical gerontologist based in Mountain View, California, USA, and is the Chief Science Officer of SENS Research Foundation, a California-based 501(c)(3) biomedical research charity that performs and funds laboratory research dedicated to combating the aging process.

He is also VP of New Technology Discovery at AgeX Therapeutics, a biotechnology startup developing new therapies in the field of biomedical gerontology. In addition, he is Editor-in-Chief of Rejuvenation Research, the world’s highest-impact peer-reviewed journal focused on intervention in aging.

He received his BA in computer science and Ph.D. in biology from the University of Cambridge. His research interests encompass the characterisation of all the types of self-inflicted cellular and molecular damage that constitute mammalian aging and the design of interventions to repair and/or obviate that damage.

Dr. de Grey is a Fellow of both the Gerontological Society of America and the American Aging Association, and sits (uncompensated) on the editorial and scientific advisory boards of numerous journals and organisations. He is a highly sought-after speaker who gives 40-50 invited talks per year at scientific conferences, universities, companies in areas ranging from pharma to life insurance, and to the public.

GREG%20HUNG_edited.png
Bildschirmfoto 2021-05-05 um 18.02.35.pn
Bildschirmfoto 2021-05-05 um 18.02.16.pn

Tony Wyss-Coray, Ph.D.

Professor of Neurology, Stanford University

Tony Wyss-Coray is the D.H. Chen Distinguished Professor of Neurology and Neurological Sciences at Stanford University. His lab studies brain aging and neurodegeneration with a focus on age-related cognitive decline and Alzheimer’s disease. The Wyss-Coray research team discovered that circulatory blood factors can modulate brain structure and function and factors from young organisms can rejuvenate old brains. Current studies focus on the molecular basis of the systemic communication with the brain by employing a combination of genetic, cell biology, and –omics approaches in killifish, mice, and humans. Wyss-Coray is the co-founder of Alkahest, a company developing plasma-based therapies to counter age-related diseases such as Alzheimer’s; he is also the recipient of an NIH Director’s Pioneer Award, a Zenith Award from the Alzheimer’s Association, a NOMIS Foundation Award, an inventor on multiple patents.

GREG%20HUNG_edited.png
Bildschirmfoto 2021-05-05 um 18.02.35.pn
Bildschirmfoto 2021-05-05 um 18.02.16.pn

Dr. Brian Kennedy

Director at Centre for Healthy Ageing and Professor Departments of Biochemistry and Physiology, National University of Singapore

Dr. Brian Kennedy is internationally recognized for his research in the basic biology of aging and as a visionary committed to translating research discoveries into new ways of detecting, delaying, preventing and treating human aging and associated diseases. He is a Distinguished Professor in Biochemistry and Physiology at the Yong Loo Lin School of Medicine at National University Singapore and serves as Director of (1) the Centre for Healthy Longevity at the National University Health System, (2) the Healthy Longevity Translational, and (3) the Asian Centre for Reproductive Longevity and Equality. Collectively, NUS aging research seeks to demonstrate that longevity interventions can be successfully employed in humans to extend healthspan, the disease-free and highly functional period of life. From 2010 to 2016, Dr. Kennedy was the President and CEO of the Buck Institute for Research on Aging and he maintained a professorship there through 2020. Dr. Kennedy has an adjunct appointments at the Department of Biochemistry at the University of Washington, where he was a faculty member from 2001 to 2010. In addition, Dr. Kennedy is also actively involved with a number of Biotechnology companies. In addition, Dr. Kennedy serves as a Co-Editor-In-Chief at Aging Cell.

Finally, Dr. Kennedy has a track record of interaction in China, where he was a Visiting Professor at the Aging Research Institute at Guangdong Medical College from 2009 to 2014. His Ph.D. was performed in the laboratory of Leonard Guarente at M.I.T., where he published the first paper linking Sirtuins to aging.

GREG%20HUNG_edited.png
Bildschirmfoto 2021-05-05 um 18.02.35.pn
Bildschirmfoto 2021-05-05 um 18.02.16.pn

Michael Greve

Founder, Forever Healthy Foundation

Michael is one of the most successful founders of the German-speaking Internet industry. Together with his brother Matthias, he created numerous ventures including lastminute.de and turned it into the largest last-minute travel site in Germany. Most notably, the brothers founded WEB.DE, and after a successful IPO, grew it into one of the country's largest internet portals and online media businesses.

After the successful sale of his companies, Michael created the seed-stage venture capital investor Kizoo that came to fund and mentor some of Germany's most promising tech startups including Babbel, Staffbase, and Mambu.
Forever Healthy started out more than a decade ago as a personal quest to shed the extremely unhealthy lifestyle he acquired while building WEB.DE, and over time turned into the focus of his entrepreneurial energy: To enable people to vastly extend their healthy lifespan and be part of the first generation to cure aging.
Initiatives of Forever Healthy include the evaluation of new rejuvenation therapies, evidenced-based curation of the world's cutting-edge medical knowledge, the annual Undoing Aging Conference, funding research projects on the root causes of aging, and supporting the creation of startups turning that research into therapies for human use.

 
 

Agenda 2021 will be announced soon

It will include the exclusive VIP part of the conference, covering topics of "How to invest in longevity?", "How can you achieve longevity?", "Is society ready for longevity?" and "Biostasis".

 

If you have questions, please feel free to contact us.

01

18

500

DAY
SPEAKERS
PARTICIPANTS
Tickets will be available soon!

Post-conference summary

It was a pleasure to welcome all of the participants to the Longevity Investors Conference! We hope that you enjoyed this experience.

For those who could not join or would like to learn more about this fascinating subject, which is longevity, we are preparing a video. 

The Venue

Due to the COVID-19 situation the Longevity Investors Conference 2021 will take place via zoom.

Longevity Investors Conference 2022 is again planned to take place in the beautiful ski resort St. Moritz (Switzerland).

 
 

Longevity Investors Conference

What

Longevity 

Investors

Conference

When

27 / 09 / 2021

03:00 PM - 07:00  PM

Where

Online Event